Biotalys
在场
Biotalys 是一家在股票代码 BTLS (NL) 下上市的公司。
高管
查看带有其 16 名主要高管的组织结构图
Biotalys 搜索最多的简介
- Kevin Helash, Chief Executive Officer and Director
- Michiel van Lookeren, Non-Executive Director
- Johan Cardoen, Non-Executive Director
高管在Biotalys变化
- Laura MeyerLaura Meyer 将于20249月24作为 Director 加入公司 (新闻发布的2024四月30号).
- Patrice Sellès, Chief Executive Officer and Director, 已经离开公司 (新闻发布的2023十月2号).
- Kevin Helash已作为Chief Executive Officer and Director加入公司 (新闻发布的2023十月2号).
创建提醒
跟踪 Biotalys 的高管变动
生物技术
Biotalys 拥有 2,284 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Karius 刚刚宣布为 100 筹款数百万美元。 (公布2024五月3号).
- Transcarent 刚刚宣布为 126 筹款数百万美元。 (公布2024五月2号).
- WindRose Health Investors has announced the acquisition of SubjectWell (公布2024五月2号).
生物技术 行业的其他推荐联系人
消息
Biotalys 的最新新闻稿
- Results of the Ordinary and Extraordinary Shareholders’ Meeting | Biotalys
- Results of the Special Shareholders’ Meeting | Biotalys
- Invitation to a Special Shareholders’ Meeting | Biotalys
- Biotalys Reports Full-Year 2023 Financial Results and Business Highlights | Biotalys
- Biotalys Enters into Academic Collaborations with Key Scientific Leaders in Europe and U.S. | Biotalys
- Biotalys Notice of Full Year 2023 Results and Business Highlights | Biotalys
- Biotalys Announces Results of Independent Field Trials in the U.S. | Biotalys
- Biotalys Provides Company Update | Biotalys
- Kevin Helash commences role as Chief Executive Officer of Biotalys | Biotalys
- Biotalys Reports Half-Year 2023 Financial Results and Business Highlights | Biotalys
- View more press releases Close
通过电子邮件
